X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
index medicus (23) 23
aged (22) 22
osteoporosis (20) 20
female (19) 19
middle aged (15) 15
aged, 80 and over (14) 14
fractures (14) 14
male (14) 14
postmenopausal women (13) 13
endocrinology & metabolism (12) 12
hip fracture (11) 11
orthopedics (11) 11
risk factors (10) 10
health aspects (9) 9
abridged index medicus (8) 8
bone-mineral density (8) 8
women (8) 8
osteoporotic fractures (7) 7
analysis (6) 6
bone density (6) 6
hip (6) 6
muscle strength (6) 6
adults (5) 5
age factors (5) 5
aging (5) 5
bone density conservation agents - therapeutic use (5) 5
geriatrics & gerontology (5) 5
gerontology (5) 5
physical medicine and rehabilitation (5) 5
prevention (5) 5
rehabilitation (5) 5
risk (5) 5
vertebral fractures (5) 5
absorptiometry, photon (4) 4
age (4) 4
bisphosphonates (4) 4
bone density - drug effects (4) 4
bones (4) 4
diagnosis (4) 4
efficacy (4) 4
endocrinology (4) 4
epidemiology (4) 4
falls (4) 4
follow-up studies (4) 4
fractures, bone - epidemiology (4) 4
fractures, bone - prevention & control (4) 4
internal medicine (4) 4
longitudinal studies (4) 4
medicine & public health (4) 4
older people (4) 4
original (4) 4
osteoporosis, postmenopausal - epidemiology (4) 4
quality of life (4) 4
risedronate (4) 4
spine (4) 4
sport sciences (4) 4
strontium ranelate (4) 4
surgery (4) 4
teriparatide (4) 4
adult (3) 3
ageing (3) 3
article (3) 3
association (3) 3
belgium (3) 3
body mass index (3) 3
bone (3) 3
bone density - physiology (3) 3
bone density conservation agents - pharmacology (3) 3
bone mineral density (3) 3
care and treatment (3) 3
clinical trials (3) 3
denosumab (3) 3
fractures, bone - etiology (3) 3
health risk assessment (3) 3
hip fractures - epidemiology (3) 3
injuries (3) 3
mass (3) 3
medicine (3) 3
medicine, general & internal (3) 3
men (3) 3
mineral density (3) 3
mortality (3) 3
obesity (3) 3
osteoporosis - drug therapy (3) 3
osteoporosis - epidemiology (3) 3
osteoporosis, postmenopausal - complications (3) 3
osteoporotic fractures - epidemiology (3) 3
osteoporotic fractures - prevention & control (3) 3
postmenopausal (3) 3
power (3) 3
research (3) 3
rheumatology (3) 3
risk-factors (3) 3
safety (3) 3
sarcopenia (3) 3
spinal fractures - complications (3) 3
teriparatide - therapeutic use (3) 3
treatment outcome (3) 3
accidental falls (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Geriatrics Society, ISSN 0002-8614, 12/2006, Volume 54, Issue 12, p. 1961
Journal Article
Journal of Bone and Joint Surgery, ISSN 0021-9355, 2012, Volume 94, Issue 23, pp. 2113 - 2119
Background Fracture is the major complication of osteoporosis, and it allows the identification of individuals needing medical intervention for osteoporosis.... 
Orthopedics
Journal Article
The American Journal of Medicine, ISSN 0002-9343, 2011, Volume 124, Issue 11, pp. 1043 - 1050
Journal Article
Chest, ISSN 0012-3692, 2011, Volume 139, Issue 3, pp. 648 - 657
COPD and osteoporosis are strongly associated because of common risk factors such as age, smoking, and inactivity. In addition, COPD-related systemic... 
Pulmonary/Respiratory | OBSTRUCTIVE PULMONARY-DISEASE | MINERAL DENSITY | US POPULATION | VERTEBRAL FRACTURES | RESPIRATORY SYSTEM | CORTICOSTEROID USE | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | HIP-FRACTURES | VITAMIN-D DEFICIENCY | CONSENSUS DOCUMENT | EVIDENCE-BASED GUIDELINES | CRITICAL CARE MEDICINE | Prevalence | Vitamin D Deficiency - complications | Humans | Calcium - administration & dosage | Vitamin D Deficiency - drug therapy | Fractures, Bone - epidemiology | Adrenal Cortex Hormones - therapeutic use | Osteoporosis - metabolism | Bone and Bones - metabolism | Vitamin D - administration & dosage | Pulmonary Disease, Chronic Obstructive - metabolism | Osteoporosis - epidemiology | Calcium - pharmacology | Osteoporosis - prevention & control | Risk Factors | Adrenal Cortex Hormones - pharmacology | Bone Density Conservation Agents - therapeutic use | Bone Density Conservation Agents - administration & dosage | Pulmonary Disease, Chronic Obstructive - complications | Bone Density Conservation Agents - pharmacology | Adrenal Cortex Hormones - adverse effects | Bone Density - drug effects | Calcium - therapeutic use | Vitamin D - therapeutic use | Vitamin D Deficiency - metabolism | Dietary Supplements | Pulmonary Disease, Chronic Obstructive - drug therapy | Prevention | Osteoporosis | Care and treatment | Lung diseases, Obstructive | Physiological aspects | Bones | Health aspects | Risk factors
Journal Article
Best Practice & Research: Clinical Endocrinology & Metabolism, ISSN 1521-690X, 2013, Volume 27, Issue 4, pp. 527 - 539
Journal Article
Archives of Physical Medicine and Rehabilitation, ISSN 0003-9993, 2013, Volume 94, Issue 11, pp. 2054 - 2060
Abstract Objective To evaluate the long-term preventive impact of strength training on muscle performance in older adults. Design A 7-year follow-up on a... 
Physical Medicine and Rehabilitation | Aging | Rehabilitation | Muscle contraction | Resistance training | Follow-up studies | VELOCITY | SPORT SCIENCES | FITNESS | QUALITY | POWER | SKELETAL-MUSCLE | MASS | WHOLE | Geriatric Assessment | Follow-Up Studies | Humans | Middle Aged | Aged, 80 and over | Female | Male | Treatment Outcome | Aged | Resistance Training - methods | Muscle Strength | Training | Weight training
Journal Article
Archives of Physical Medicine and Rehabilitation, ISSN 0003-9993, 2011, Volume 92, Issue 11, pp. 1827 - 1832
Journal Article
Journal of the American Geriatrics Society, ISSN 0002-8614, 05/2006, Volume 54, Issue 5, pp. 782 - 789
OBJECTIVES: To assess the safety and efficacy of teriparatide in patients aged 75 and older and compare these findings with those of women younger than 75... 
geriatric patients | teriparatide | osteoporosis | safety | elderly | efficacy | Osteoporosis | Efficacy | Safety | Elderly | Teriparatide | Geriatric patients | TRIALS | PARATHYROID-HORMONE 1-34 | OLDER | RISK | VERTEBRAL FRACTURE | GERIATRICS & GERONTOLOGY | HIP FRACTURE | MINERAL DENSITY | MASS | GERONTOLOGY | RISEDRONATE | POSTMENOPAUSAL WOMEN | Lumbar Vertebrae - injuries | Teriparatide - pharmacology | Teriparatide - therapeutic use | Age Factors | Double-Blind Method | Humans | Osteoporosis, Postmenopausal - complications | Bone Density Conservation Agents - therapeutic use | Treatment Outcome | Hypercalcemia - epidemiology | Bone Remodeling - drug effects | Osteoporosis, Postmenopausal - drug therapy | Bone Density Conservation Agents - pharmacology | Incidence | Bone Density - drug effects | Fractures, Bone - etiology | Aged, 80 and over | Female | Femur Neck - physiopathology | Osteoporosis, Postmenopausal - physiopathology | Aged | Hyperuricemia - epidemiology | Fractures, Bone - prevention & control | Lumbar Vertebrae - physiopathology | Aging | Health aspects | Aged women | Women | Older people | Clinical trials | Drug therapy | Geriatrics | Postmenopausal | injuries | 80 and over | epidemiology | Hyperuricemia | Endokrinologi och diabetes | Bone Density Conservation Agents | pharmacology | Endocrinology and Diabetes | Bone Density | drug therapy | complications | drug effects | Femur Neck | prevention & control | etiology | Hypercalcemia | physiopathology | Fractures | Bone | Lumbar Vertebrae | therapeutic use | Bone Remodeling
Journal Article
16.